Concepedia

Shubham Pant

SP

Statistics

Publications

135

Citations

9.3K

H-Index

46

Active since

2005

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Sarah Cannon

Tennessee Oncology

Memorial Sloan Kettering Cancer Center

University of Oklahoma Health Sciences Center

Shubham Pant is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

2005–2025

135

Publications

135

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky et al. · The Lancet · 2015 · 1.2K citations

, , +16

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

Zev A. Wainberg, Davide Melisi, Teresa Macarulla et al. · The Lancet · 2023 · 439 citations · Full text

, , +11

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

Timothy A. Yap, Naval Daver, Mikhila Mahendra et al. · Nature Medicine · 2023 · 377 citations

, , +14

Metastatic Pancreatic Cancer: ASCO Guideline Update

Davendra Sohal, Erin B. Kennedy, Pelin Cinar et al. · Journal of Clinical Oncology · 2020 · 289 citations · Full text

, , +17

Adagrasib in Advanced Solid Tumors Harboring a<i>KRAS</i><sup><i>G12C</i></sup>Mutation

Tanios Bekaii‐Saab, Rona Yaeger, Alexander I. Spira et al. · Journal of Clinical Oncology · 2023 · 276 citations · Full text

, , +13

1–5 of 135